|
|||||
|
|
Chronopharmacology of nebicapone,a new catechol-O-methyltransferase inhibitor |
|
| Abstract: | Abstract Objective:To investigate the chronopharmacology of nebicapone, a new catechol-O-methyltransferase (COMT) inhibitor currently being developed for use as an adjunct to levodopa/carbidopa or levodopa/benserazide in the treatment of Parkinson’s disease. |
| Keywords: | Catechol-O-methyltransferase inhibitors Chronopharmacokinetics Chronopharmacology Nebicapone Parkinson’s disease |